X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5065) 5065
Book Chapter (38) 38
Magazine Article (7) 7
Newsletter (5) 5
Book / eBook (3) 3
Reference (3) 3
Newspaper Article (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (3986) 3986
life sciences & biomedicine (3727) 3727
male (3480) 3480
animals (3467) 3467
memory disorders - chemically induced (2585) 2585
neurosciences & neurology (2162) 2162
neurosciences (2104) 2104
memory (1952) 1952
rats (1853) 1853
humans (1841) 1841
female (1474) 1474
maze learning - drug effects (1220) 1220
mice (1174) 1174
memory - drug effects (1133) 1133
pharmacology & pharmacy (1067) 1067
disease models, animal (979) 979
rats, wistar (868) 868
hippocampus - drug effects (856) 856
cognition disorders - chemically induced (813) 813
adult (769) 769
psychiatry (748) 748
memory disorders - drug therapy (713) 713
dose-response relationship, drug (664) 664
rats, sprague-dawley (653) 653
hippocampus (632) 632
alzheimer's disease (564) 564
hippocampus - metabolism (546) 546
behavior, animal - drug effects (532) 532
time factors (519) 519
behavioral sciences (517) 517
rodents (517) 517
memory disorders - physiopathology (510) 510
brain (509) 509
brain - drug effects (496) 496
avoidance learning - drug effects (488) 488
middle aged (485) 485
analysis (480) 480
cognitive ability (476) 476
neurology (476) 476
learning (472) 472
neuropsychological tests (464) 464
cognition (433) 433
cognition - drug effects (427) 427
clinical neurology (409) 409
memory disorders - metabolism (396) 396
analysis of variance (383) 383
mice, inbred c57bl (368) 368
research (362) 362
brain - metabolism (360) 360
memory, short-term - drug effects (359) 359
memory - physiology (352) 352
memory disorders - psychology (344) 344
psychology (338) 338
motor activity - drug effects (335) 335
hippocampus - pathology (327) 327
aged (319) 319
memory disorders - prevention & control (319) 319
biomedicine (311) 311
social sciences (309) 309
oxidative stress (304) 304
maze learning - physiology (296) 296
spatial memory (291) 291
learning disorders - chemically induced (285) 285
neurons - drug effects (276) 276
neuroprotective agents - pharmacology (275) 275
oxidative stress - drug effects (273) 273
learning and memory (267) 267
adolescent (262) 262
scopolamine (258) 258
toxicology (253) 253
proteins (246) 246
neurons (244) 244
reaction time - drug effects (244) 244
memory disorders - pathology (243) 243
biochemistry & molecular biology (240) 240
hippocampus - physiopathology (240) 240
pregnancy (240) 240
research article (237) 237
learning - drug effects (233) 233
acetylcholinesterase - metabolism (229) 229
science & technology - other topics (224) 224
physiological aspects (216) 216
recognition - drug effects (214) 214
medicine (212) 212
abridged index medicus (210) 210
multidisciplinary sciences (208) 208
schizophrenia (208) 208
cell biology (204) 204
memory disorders - etiology (203) 203
nervous system (203) 203
cognition disorders - psychology (201) 201
health aspects (200) 200
risk factors (199) 199
inflammation (197) 197
cognition disorders - drug therapy (194) 194
exploratory behavior - drug effects (189) 189
rat (189) 189
aging (187) 187
psychomotor performance - drug effects (187) 187
animals, newborn (184) 184
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5016) 5016
Japanese (63) 63
Chinese (54) 54
French (28) 28
Russian (25) 25
German (17) 17
Spanish (14) 14
Danish (6) 6
Portuguese (6) 6
Polish (5) 5
Swedish (4) 4
Dutch (3) 3
Italian (3) 3
Hungarian (2) 2
Norwegian (2) 2
Croatian (1) 1
Hebrew (1) 1
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Addiction (Abingdon, England), ISSN 1360-0443, 01/2010, Volume 105, Issue 1, pp. 121 - 133
Background  `Recreational' use of ketamine is spreading rapidly among young people. In healthy individuals an acute dose of the N-methyl D-aspartate (NMDA)... 
cognition | learning and memory | ketamine | recreational use | Chronic use | NMDA receptor antagonist | dependence | depression | longitudinal | glutamate | addiction and substance abuse | Learning and memory | Recreational use | Ketamine | Longitudinal | Dependence | Depression | Cognition | Addiction and substance abuse | Glutamate | Life Sciences & Biomedicine | Substance Abuse | Psychiatry | Science & Technology | Memory - drug effects | Delusions - epidemiology | Follow-Up Studies | Cognition Disorders - chemically induced | Humans | Male | Memory Disorders - diagnosis | Educational Status | Statistics as Topic | Dissociative Disorders - epidemiology | Dose-Response Relationship, Drug | Dissociative Disorders - chemically induced | Ketamine - adverse effects | Psychiatric Status Rating Scales | Time Factors | Substance-Related Disorders - epidemiology | Adult | Female | Depressive Disorder - chemically induced | Depressive Disorder - epidemiology | Excitatory Amino Acid Antagonists - adverse effects | Self Medication - psychology | Cognition Disorders - psychology | Memory Disorders - epidemiology | Self Medication - statistics & numerical data | Excitatory Amino Acid Antagonists - pharmacology | Delusions - chemically induced | Neuropsychological Tests | Recognition (Psychology) - drug effects | Speech Disorders - chemically induced | Speech Disorders - epidemiology | Substance-Related Disorders - psychology | Ketamine - pharmacology | Cognition Disorders - epidemiology | Memory Disorders - chemically induced | Illegal drugs | Methyl aspartate | Substance abuse | Depression, Mental | Drug abuse | Mental depression | Cognitive ability | Mental health | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2016, Volume 375, Issue 18, pp. 1717 - 1725
Three patients had severe ataxia and memory impairment in a phase 1 trial of a fatty acid amide hydrolase inhibitor designed as an analgesic and... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Male | Cyclic N-Oxides - administration & dosage | Healthy Volunteers | Cerebral Hemorrhage - diagnosis | Pyridines - adverse effects | Cyclic N-Oxides - adverse effects | Adult | Headache - chemically induced | Brain Death | Cerebral Hemorrhage - chemically induced | Acute Disease | Pons - pathology | Pyridines - administration & dosage | Double-Blind Method | Administration, Oral | Amidohydrolases - antagonists & inhibitors | Hippocampus - pathology | Cerebellum - pathology | Consciousness Disorders - chemically induced | Magnetic Resonance Imaging | Cerebellar Diseases - chemically induced | Gait Ataxia - chemically induced | Memory Disorders - chemically induced | Nervous system diseases | Care and treatment | Dosage and administration | Drug testing | Acetylaminofluorene | Fatty-acid amide hydrolase | Cerebellum | Neuroimaging | Headache | Enzymes | Pons | Animal models | Inhibitor drugs | Hydrolase | Toxicity | Memory | Oral administration | Fatty acids | Patients | Cannabinoids | Magnetic resonance imaging | Patient safety | Drug dosages | Hippocampus | Neurological disorders | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Neurons and Cognition | Psychiatrics and mental health
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2017, Volume 146, Issue 2, pp. 386 - 391
Abstract Objectives Women with ovarian cancer can have long overall survival and goals of treatment change over time from cure to remission to stable disease.... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Peripheral Nervous System Diseases - chemically induced | Diarrhea - psychology | Nausea - chemically induced | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Fatigue - chemically induced | Pain - chemically induced | Diarrhea - chemically induced | Arthralgia - chemically induced | Gastroesophageal Reflux - chemically induced | Nausea - psychology | Alopecia - psychology | Young Adult | Constipation - psychology | Patient Care Planning | Sexual Dysfunction, Physiological - psychology | Antineoplastic Agents - adverse effects | Adult | Female | Surveys and Questionnaires | Neoplasm Recurrence, Local - psychology | Survivors - psychology | Gastroesophageal Reflux - psychology | Ovarian Neoplasms - drug therapy | Arthralgia - psychology | Ovarian Neoplasms - psychology | Memory Disorders - psychology | Attitude to Health | Peripheral Nervous System Diseases - psychology | Fatigue - psychology | Sexual Dysfunction, Physiological - chemically induced | Drug-Related Side Effects and Adverse Reactions - etiology | Hospitalization | Remission Induction | Constipation - chemically induced | Vomiting - chemically induced | Pain - psychology | Adolescent | Vomiting - psychology | Quality of Life | Alopecia - chemically induced | Aged | Neoplasm Staging | Drug-Related Side Effects and Adverse Reactions - psychology | Memory Disorders - chemically induced | Complications and side effects | Ovarian cancer | Index Medicus
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 05/2006, Volume 31, Issue 5, pp. 1036 - 1047
Cognitive function was assessed in chronic drug users on neurocognitive measures of executive and memory function. Current amphetamine users were contrasted... 
Amphetamines | Opiates | Impulsivity | Substance abuse | Neuropsychological assessment | Abstinence | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Memory Disorders - physiopathology | Brain Damage, Chronic - diagnosis | Cognition Disorders - chemically induced | Humans | Learning Disorders - physiopathology | Male | Memory Disorders - diagnosis | Time | Space Perception - physiology | Space Perception - drug effects | Adult | Female | Temporal Lobe - pathology | Brain Damage, Chronic - chemically induced | Cognition Disorders - physiopathology | Opioid-Related Disorders - psychology | Learning Disorders - diagnosis | Frontal Lobe - physiopathology | Amphetamine-Related Disorders - physiopathology | Sex Characteristics | Brain Damage, Chronic - physiopathology | Neuropsychological Tests | Cognition Disorders - diagnosis | Learning Disorders - chemically induced | Temporal Lobe - physiopathology | Frontal Lobe - drug effects | Amphetamine-Related Disorders - psychology | Opioid-Related Disorders - physiopathology | Temporal Lobe - drug effects | Amphetamine-Related Disorders - complications | Frontal Lobe - pathology | Memory Disorders - chemically induced | Opioid-Related Disorders - complications | Index Medicus | abstinence | impulsivity | neuropsychological assessment | substance abuse | amphetamines | opiates
Journal Article
Journal Article
Alcohol, ISSN 0741-8329, 2016, Volume 51, pp. 1 - 15
Journal Article
Journal Article
Brain Research, ISSN 0006-8993, 2015, Volume 1631, pp. 137 - 146
Abstract Our previous studies demonstrated that tanshinone IIA (tan IIA) has significant protective effects against the neurotoxicity induced by β-amyloid protein (Aβ... 
Neurology | Tanshinone IIA | Oxidative stress | Memory deficits | Acetylcholinesterase | Streptozotocin | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Cognition Disorders - chemically induced | Cognition Disorders - metabolism | Male | Hippocampus - drug effects | Parietal Lobe - metabolism | Cerebral Cortex - metabolism | Dose-Response Relationship, Drug | Neuroprotective Agents - pharmacology | Parietal Lobe - drug effects | Amyloid beta-Peptides - metabolism | Hippocampus - enzymology | Neurons - metabolism | p38 Mitogen-Activated Protein Kinases - metabolism | Alzheimer Disease - chemically induced | Neurons - drug effects | Superoxide Dismutase - metabolism | Disease Models, Animal | Malondialdehyde - metabolism | Alzheimer Disease - drug therapy | Random Allocation | Streptozocin - administration & dosage | Cognition Disorders - drug therapy | Maze Learning - drug effects | Hippocampus - metabolism | Diterpenes, Abietane - pharmacology | Animals | Memory Disorders - drug therapy | Alzheimer Disease - metabolism | Mice | Oxidative Stress - drug effects | Infusions, Intraventricular | Acetylcholinesterase - metabolism | Memory Disorders - chemically induced | Parietal Lobe - enzymology | Human anatomy | Streptozocin | Neurons | Analysis | Superoxide | Mitogens | Protein kinases | Alzheimer's disease | Neurophysiology | Index Medicus
Journal Article